Sodium Acetate (Hospira, Inc.)
Welcome to the PulseAid listing for the Sodium Acetate drug offered from Hospira, Inc.. This Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Hospira, Inc. |
| NON-PROPRIETARY NAME: | SODIUM ACETATE |
| SUBSTANCE NAME: | SODIUM ACETATE ANHYDROUS |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION, CONCENTRATE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2014-03-05 |
| END MARKETING DATE: | 0000-00-00 |
Sodium Acetate HUMAN PRESCRIPTION DRUG Details:
| Item Description | Sodium Acetate from Hospira, Inc. |
| LABELER NAME: | Hospira, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 3.28(g/20mL) |
| START MARKETING DATE: | 2014-03-05 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0409-7299_74e30ff1-aed2-46b9-8caf-1e3509084b15 |
| PRODUCT NDC: | 0409-7299 |
| APPLICATION NUMBER: | NDA018893 |
Other SODIUM ACETATE ANHYDROUS Pharmaceutical Manufacturers / Labelers:
